2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: BIOLOGICAL: Bevacizumab and Paclitaxel|BIOLOGICAL: Bevacizumab and Capecitabine
Sponsor: Central European Cooperative Oncology Group